Asia | International | Updates
Korea: Mesothelioma to Rise for Another 30 Years
While mesothelioma rates are expected to start declining in the U.S. within the next decade, Korea’s war on against this…
Clinical Trials Offer Options for Mesothelioma
Mesothelioma is a devastating malignancy in the lining of the lungs and other internal organs. It affects about 2,500 Americans…
Possible Second-Line Mesothelioma Treatment Fails
There has been some disappointing news for mesothelioma patients who fail to respond to first-line chemotherapy treatment. A major Phase…
Pricey Mesothelioma Drug May be Best Second-Line Treatment
The chemotherapy combination of pemetrexed (brand name Alimta) and cisplatin is typically the first-line drug treatment for patients with advanced…
Libby Residents Settle Mesothelioma and Asbestos Lawsuits
Residents of Libby, Montana who have contracted mesothelioma and other disease from exposure to asbestos will share a $43 million dollar settlement.…
New Clues How Asbestos Causes Mesothelioma
A team of Japanese researchers believe they may have found another piece of the puzzle explaining why asbestos causes malignant mesothelioma. Asbestos…
Rare Form of Mesothelioma Appears after Multimodal Treatment
Advanced mesothelioma treatment approaches like multimodal therapy may not only prolong survival in some patients; they may also cause fundamental…
Mesothelioma Risk Still Exists After 9/11
A decade after the attack on the World Trade Centers, health officials are bracing for latent health effects such as mesothelioma among…
Study Confirms Mesothelioma Danger for Home Renovators
An Australian study reconfirms that performing home renovations on homes built before the 1980’s can put a person at increased…
Multi-Modality Mesothelioma Treatment Well Tolerated
The combination of pleurectomy/decortication, hyperthermic pleural lavage and adjuvant chemotherapy is an effective alternative to more traditional mesothelioma treatment combinations.…